Assertion: epinephrine | /r/HasProperty | systemic
Facets:
Source sentences:
text: EPINEPHrine (Systemic)
text: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Beta-Blockers (Beta1 Selective): May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Beta-Blockers (Nonselective): May enhance the hypertensive effect of EPINEPHrine (Systemic).
text: Beta-Blockers (with Alpha-Blocking Properties): May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Blonanserin: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Bromperidol: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Inhalational Anesthetics: May enhance the arrhythmogenic effect of EPINEPHrine (Systemic).
text: Lurasidone: EPINEPHrine (Systemic) may enhance the hypotensive effect of Lurasidone.
text: Monoamine Oxidase Inhibitors: May enhance the hypertensive effect of EPINEPHrine (Systemic).
text: May diminish the vasoconstricting effect of EPINEPHrine (Systemic).
text: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Beta-Blockers (Beta1 Selective): May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Beta-Blockers (Nonselective): May enhance the hypertensive effect of EPINEPHrine (Systemic).
text: Beta-Blockers (with Alpha-Blocking Properties): May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Blonanserin: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Bromperidol: May diminish the therapeutic effect of EPINEPHrine (Systemic).
text: Inhalational Anesthetics: May enhance the arrhythmogenic effect of EPINEPHrine (Systemic).
text: Lurasidone: EPINEPHrine (Systemic) may enhance the hypotensive effect of Lurasidone.
text: Monoamine Oxidase Inhibitors: May enhance the hypertensive effect of EPINEPHrine (Systemic).
text: May diminish the vasoconstricting effect of EPINEPHrine (Systemic).